Funny, I believe it is a fully accurate evaluation considering the low O/S and fact that regen is about to start clinical trials and have various inds on the way, seems to me like its coming, and 100k for 100k is fully viable and a reasonable share structure. The fact that hicks is involved has literally nothing to do valuation; historical events are not indicative of future. We will see a large gain through regen and bmsn. Time for a big fun bmsn friends.